We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+12.35%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$5.09B
AUM Growth
+$1.38B
Cap. Flow
+$926M
Cap. Flow %
18.19%
Top 10 Hldgs %
35.13%
Holding
112
New
25
Increased
38
Reduced
18
Closed
24

Top Buys

Rank Stock Value
1
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$137M
2
AGN.PRA
Allergan plc
AGN.PRA
+$89.2M
3
CNC icon
Centene
CNC
+$76.1M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$57.1M
5
JD icon
JD.com
JD
+$52M

Top Sells

Rank Stock Value
1
KITE
Kite Pharma, Inc.
KITE
+$243M
2
UHS icon
Universal Health Services
UHS
+$91.1M
3
PCRX icon
Pacira BioSciences
PCRX
+$87.8M
4
MCK icon
McKesson
MCK
+$72.1M
5
BABA icon
Alibaba
BABA
+$54.9M

Sector Composition

Rank Sector Weight
1 Healthcare 33.12%
2 Technology 12.48%
3 Communication Services 5.27%
4 Consumer Discretionary 4.56%
5 Financials 3.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$471B
$393M 7.72%
2,699,900
+1,982,700
+276% +$284M
PTLA
2
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$274M 5.39%
5,078,146
+2,332,304
+85% +$137M
PFE icon
3
CALL
Pfizer
PFE
$142B
$201M 3.94%
+5,920,529
New +$190M
XBI icon
4
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$184M 3.62%
+2,126,900
New +$171M
PBYI icon
5
Puma Biotechnology
PBYI
$422M
$164M 3.22%
1,369,579
-312,579
-19% -$29.1M
ELV icon
6
Elevance Health
ELV
$82.9B
$120M 2.36%
632,321
+77,005
+14% +$14.7M
AERI
7
DELISTED
Aerie Pharmaceuticals
AERI
$117M 2.3%
2,413,461
+665,421
+38% +$36.3M
BPMC
8
DELISTED
Blueprint Medicines
BPMC
$113M 2.23%
1,629,086
+342,636
+27% +$18.3M
EW icon
9
Edwards Lifesciences
EW
$48.9B
$113M 2.23%
3,112,272
+1,267,839
+69% +$48.4M
GDDY icon
10
GoDaddy
GDDY
$12.2B
$108M 2.12%
2,482,695
+375,052
+18% +$16.2M
BAX icon
11
Baxter International
BAX
$11.5B
$103M 2.03%
1,642,668
+462,086
+39% +$28.5M
META icon
12
Meta Platforms (Facebook)
META
$1.63T
$101M 1.98%
588,286
+282,087
+92% +$47.1M
ABT icon
13
Abbott
ABT
$174B
$96.1M 1.89%
1,800,968
+698,187
+63% +$35M
ACOR
14
DELISTED
Acorda Therapeutics
ACOR
$95.8M 1.88%
33,769
+12,201
+57% +$32.1M
AMZN icon
15
Amazon
AMZN
$2.66T
$90.7M 1.78%
1,886,640
+678,400
+56% +$33.3M
CRM icon
16
Salesforce
CRM
$139B
$89.3M 1.75%
955,567
+506,867
+113% +$46.6M
CNC icon
17
Centene
CNC
$32.5B
$85.6M 1.68%
+1,768,650
New +$76.1M
GOOGL icon
18
Alphabet (Google) Class A
GOOGL
$4.24T
$84.5M 1.66%
1,735,680
+908,120
+110% +$43.1M
GDX icon
19
PUT
VanEck Gold Miners ETF
GDX
$22.7B
$82.1M 1.61%
+879,300
New +$20.3M
CI icon
20
Cigna
CI
$76.8B
$79.9M 1.57%
427,374
+63,129
+17% +$11.2M
AGN.PRA
21
DELISTED
Allergan plc
AGN.PRA
$79.2M 1.56%
+107,410
New +$89.2M
JD icon
22
JD.com
JD
$41.1B
$78.6M 1.55%
2,058,588
+1,215,887
+144% +$52M
MSFT icon
23
Microsoft
MSFT
$2.95T
$78M 1.53%
1,046,867
-128,436
-11% -$9.38M
ATVI
24
DELISTED
Activision Blizzard
ATVI
$71.5M 1.4%
1,107,904
+614,128
+124% +$38.3M
ZAYO
25
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$69.5M 1.36%
2,017,797
+928,728
+85% +$30.8M
1
2 3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
AWP
Abacus Wealth Partners Santa Monica, California $1.1B AUM 14.74% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

PFM Health Sciences's Q3 2017 Portfolio in Review

As of Q3 2017, PFM Health Sciences held 112 positions worth $5.09B, up 37% from $3.71B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

PFM Health Sciences deployed $926M of net new capital in Q3 2017, opening 25 new positions and adding to 38 existing holdings. Its largest new stake was Allergan plc: 107,410 shares worth $79.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Kite Pharma, Inc., an estimated $243M trimmed.

  • PFM Health Sciences's largest Q3 2017 buy was Allergan plc: 107,410 shares worth $79.2M.
  • PFM Health Sciences added most to Portola Pharmaceuticals, Inc. in Q3 2017, an estimated $137M increase.
  • PFM Health Sciences's biggest Q3 2017 reduction was Kite Pharma, Inc., cutting an estimated $243M.
  • PFM Health Sciences fully exited Universal Health Services in Q3 2017, selling an estimated $91.1M.
  • PFM Health Sciences's ten largest holdings make up 35% of its $5.09B portfolio in Q3 2017.
  • PFM Health Sciences opened 25 new positions and closed 24 in Q3 2017.
  • PFM Health Sciences's portfolio value rose 37% quarter-over-quarter to $5.09B.

Based on PFM Health Sciences's 13F filing for Q3 2017, filed 14 Nov 2017.